Latest Strategic Partnerships News

AGL Energy reported a 575% surge in statutory profit to $756 million for FY26, driven by strategic divestments and improved asset flexibility, while declaring a fully franked 50 cents dividend and progressing its energy transition with 12 GW of renewable capacity targeted by 2035.

Starpharma has successfully completed a $32 million entitlement offer, nearly fully subscribed, to fund its DEP® HER2-Lutetium Phase 1 trial and further develop its oncology pipeline.

Nanoveu has landed a US$300,000 pilot order to deploy its EyeFly3D™ glasses-free 3D mobile films across India via an OEM agreement with One Immersive Inc., targeting a major OTT platform with over 100 million monthly users.

MRG Metals has secured $800,000 through a placement and board commitment to accelerate development at its ultra high-grade Garies Rare Earth Project in South Africa and advance exploration in Mozambique.

ReNerve Limited has gained marketing approval for its flagship NervAlign Nerve Cuff in India, marking a critical milestone in its global expansion and enabling commercial rollout in one of the world's largest nerve repair markets.

Sky Metals releases a Pre-Feasibility Study confirming Tallebung's robust economics with a 7.3-year mine life, strong cashflows, and rapid capital payback, targeting mid-2028 production.

Contact Energy (ASX:CEN) posted a 62% jump in FY26 net profit to NZD 423 million, driven by its Manawa acquisition and a near 98% renewable generation mix, while committing to net zero emissions by 2035.

Viridis Mining's Demonstration Plant for Mixed Rare Earth Carbonate production has outperformed Pre-Feasibility Study assumptions, achieving average magnetic rare earth oxide recoveries near 79% during steady operation in July 2026.

Harris Technology’s refurbished tech division surpassed $1 million in monthly sales for the first time in July 2026, nearly doubling year-on-year revenue and becoming the company’s main earnings driver.

Acrux Limited spotlighted its Female Testosterone Metered Dose Transdermal System (MDTS) at the Bioshares Biotech Summit, revealing positive Phase II data and outlining a clear regulatory and commercial roadmap targeting Hypoactive Sexual Desire Disorder (HSDD) in women.

Spacetalk Ltd has locked in $10 million through a two-tranche share placement, aiming to fund platform enhancements, inventory growth, and a major network migration.

Mastermyne has secured a major new mining services contract at the Dendrobium coal mine, potentially worth $255 million over six years and adding over 140 new roles.